MI4 is an independent advisory team dedicated to helping organizations plan, launch, and scale molecular imaging and theranostics programs. Led by healthcare strategist Manuel Paris and physician executive Joseph Osborne, MD, PhD, MI4 provides senior-level guidance across clinical strategy, radiopharmaceutical readiness, operations, infrastructure, and financial viability. To support complex initiatives, MI4 has assembled a curated network of top-tier consultants and subject matter experts across nuclear medicine, oncology, radiopharmacy, regulatory strategy, operations, and healthcare finance. This model allows clients to access precisely the expertise required without the overhead of traditional consulting firms. We engage with organizations facing real implementation decisions — from early feasibility assessment through full program launch and expansion. HOW WE HELP Program Feasibility & Readiness Assessment Independent evaluation of market demand, infrastructure needs, risks, and investment requirements Theranostics Program Launch Planning Roadmap from concept to operational readiness Radiopharmaceutical & Technology Strategy Supply considerations, modality planning, regulatory landscape Operational & Facility Planning Workflow design, staffing models, safety protocols, capacity planning Financial Modeling & Business Case Development Capital planning, reimbursement outlook, ROI analysis Leadership Alignment & Change Management Cross-functional coordination and implementation readiness 👉 Contact MI4 to discuss your organization’s readiness for theranostics or molecular imaging expansion.
| Website | http://www.mi4vm.com |
| Employees | 4 (0 on RocketReach) |
| Founded | 2018 |
| Industry | Hospitals and Health Care |
Looking for a particular MI4 VM LLC employee's phone or email?
MI4 VM LLC Questions
Related Companies
